Taiwan Liposome Company, Ltd. American Depository Shares
TLC
TLC was delisted on the 28th of September, 2021.
4 hedge funds and large institutions have $193K invested in Taiwan Liposome Company, Ltd. American Depository Shares in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
20% less funds holding
Funds holding: 5 → 4 (-1)
46% less capital invested
Capital invested by funds: $358K → $193K (-$165K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$69.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$167K |
| 2 |
Jane Street
New York
|
-$64K |
| 3 |
HR
Howe & Rusling
Rochester,
New York
|
-$2K |
TLC Hedge Fund Activity: Q4 2020 in Review
4 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Taiwan Liposome Company, Ltd. American Depository Shares (TLC) for Q4 2020, worth a combined $193K — down 46% from $358K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of TLC and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $69.4K. The largest seller was Millennium Management, exiting entirely with an estimated $167K sold.
- 4 institutional investors held Taiwan Liposome Company, Ltd. American Depository Shares (TLC) as of Q4 2020, down from 5 in Q3 2020.
- Funds reported $193K of Taiwan Liposome Company, Ltd. American Depository Shares stock for Q4 2020, down 46% quarter-over-quarter.
- 1 fund opened new Taiwan Liposome Company, Ltd. American Depository Shares positions in Q4 2020 and 2 closed out, a net change of -1 holder.
- The largest Taiwan Liposome Company, Ltd. American Depository Shares buyer in Q4 2020 was Renaissance Technologies, an estimated $69.4K added.
- The largest Taiwan Liposome Company, Ltd. American Depository Shares seller in Q4 2020 was Millennium Management, an estimated $167K sold.
Based on aggregated 13F filings for Q4 2020.